Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Gross

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology Clinics of North America|May 25, 2010
Ashkenazi Jewish screening in the twenty-first centurySusan Klugman, Susan J Gross
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 3, 2014
The genetics of diabetic pregnancyKomal Bajaj, Susan J Gross
Prenatal Diagnosis|January 10, 2019
Noninvasive screening by cell-free DNA for 22q11.2 deletion: Benefits, limitations, and challengesFrancesca Romana Grati, Susan J Gross
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 17, 2008
First trimester diagnosis and screening for fetal aneuploidyDeborah A Driscoll, Susan J Gross,
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 17, 2009
Screening for fetal aneuploidy and neural tube defectsDeborah A Driscoll, Susan J Gross,
Nature|July 17, 2015
Prenatal screening: Focus on more specific fetal testingSusan J Gross, Stephanie Kareht, Allison Ryan
American Journal of Obstetrics and Gynecology|June 14, 2015
Positive predictive values and false-positive results in noninvasive prenatal screeningPe'er Dar, Susan J Gross, Peter Benn
American Journal of Obstetrics and Gynecology|May 6, 2015
Reply: To PMID 25111587Pe'er Dar, Susan J Gross, Peter Benn
American Journal of Obstetrics and Gynecology|May 20, 2015
Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive valueSusan J Gross, Allison Ryan, Peter Benn
Obstetrics and Gynecology|July 4, 2006
A surprising postnatal diagnosisNatasha Shur, Robert Marion, Susan J Gross
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology Clinics of North America|May 25, 2010
Ashkenazi Jewish screening in the twenty-first centurySusan Klugman, Susan J Gross
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 3, 2014
The genetics of diabetic pregnancyKomal Bajaj, Susan J Gross
Prenatal Diagnosis|January 10, 2019
Noninvasive screening by cell-free DNA for 22q11.2 deletion: Benefits, limitations, and challengesFrancesca Romana Grati, Susan J Gross
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 17, 2008
First trimester diagnosis and screening for fetal aneuploidyDeborah A Driscoll, Susan J Gross,
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 17, 2009
Screening for fetal aneuploidy and neural tube defectsDeborah A Driscoll, Susan J Gross,
Nature|July 17, 2015
Prenatal screening: Focus on more specific fetal testingSusan J Gross, Stephanie Kareht, Allison Ryan
American Journal of Obstetrics and Gynecology|June 14, 2015
Positive predictive values and false-positive results in noninvasive prenatal screeningPe'er Dar, Susan J Gross, Peter Benn
American Journal of Obstetrics and Gynecology|May 6, 2015
Reply: To PMID 25111587Pe'er Dar, Susan J Gross, Peter Benn
American Journal of Obstetrics and Gynecology|May 20, 2015
Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive valueSusan J Gross, Allison Ryan, Peter Benn
Obstetrics and Gynecology|July 4, 2006
A surprising postnatal diagnosisNatasha Shur, Robert Marion, Susan J Gross
Pageof 5